Raphael Pharmaceutical (RAPH) Change in Account Payables (2020 - 2025)

Raphael Pharmaceutical has disclosed Change in Account Payables across 6 years of filings, most recently posting $291000.0 for Q4 2025.

• Change in Account Payables for Q4 2025 came in at $291000.0, up 171.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $818000.0 (up 330.53% YoY), and the FY2025 annual result was $818000.0, up 330.53% from the prior year.
• Change in Account Payables came in at $291000.0 for Q4 2025 at Raphael Pharmaceutical, up from $191000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $421000.0 in Q3 2023 to a low of -$405000.0 in Q4 2024.
• The 5-year median for Change in Account Payables is $42500.0 (2021), against an average of $62900.0.
• Across the five-year window, Change in Account Payables tumbled 10300.0% in 2023 and surged 831.58% in 2025, its largest moves.
• Raphael Pharmaceutical's Change in Account Payables stood at $94000.0 in 2021, then plunged by 162.77% to -$59000.0 in 2022, then sank by 266.1% to -$216000.0 in 2023, then tumbled by 87.5% to -$405000.0 in 2024, then jumped by 171.85% to $291000.0 in 2025.
• The last three Change in Account Payables figures came in at $291000.0 (Q4 2025), $191000.0 (Q3 2025), and $278000.0 (Q2 2025), per Business Quant data.